WinstonWınston
PrimeMD logo

PrimeMD

PRMD
65
Medical - Care Facilities · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$5,550
Winston Score
65
Winston is curious
A decent business — some strong pillars, some weaker.

Share count rising — dilution

+502.0% over 16y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 3.1M (2005) → 18.5M (2021)

PrimeMD Inc. is a small healthcare technology company that connects patients with doctors through telehealth services. Instead of visiting a clinic in person, patients can consult licensed physicians online, typically for common health concerns and prescription needs. The company operates in the growing digital health space, focusing on making basic medical care more accessible and convenient.

PrimeMD earns revenue by charging patients directly for virtual consultations, which explains its 100% gross margin — a sign that it delivers services digitally with minimal physical costs. The company appears to operate primarily in the United States and remains very small, with a market cap close to zero, meaning it is a micro-cap or early-stage business. Its main growth driver is the continued adoption of telehealth by patients and insurers, but its biggest risk is intense competition from much larger platforms like Teladoc and Amazon Clinic, which have far greater resources and brand recognition.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
100.0%
Premium pricing power — 100.0% gross margin
Operating Margin
211.5%
Excellent — 211.5% operating margin
ROCE
24.0%
Exceptional — 24.0% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
Data not available
EPS YoY
N/A
Data not available
EPS Consistency
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
96%
Turns 96% of profit into real cash
FCF Margin
21.4%
Converts sales into free cash efficiently (21.4%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.97
Moderate — manageable debt (0.97)
Interest Cover
18.68x
Comfortably covers interest (18.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.0x
Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial